Bionik Laboratories (OTCMKTS:BNKL) Stock Crosses Above 50-Day Moving Average – Time to Sell?

Bionik Laboratories Corp. (OTCMKTS:BNKL – Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Bionik Laboratories shares last traded at $0.00, with a volume of 0 shares traded.

Bionik Laboratories Trading Down 100.0%

Get Bionik Laboratories alerts:

About Bionik Laboratories

(Get Free Report)

Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.

Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations.

Further Reading

• Five stocks we like better than Bionik Laboratories
• Is Best Buy the AI Winner Hiding in the Electronics Aisle?
• Applied Materials Beat Everything but Wall Street’s Expectations for Margins
• Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
• Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing

Receive News & Ratings for Bionik Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionik Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.